Study Summary
A Clinical Study to Investigate the Safety and Efficacy of CT0991 in Patients with Relapsed/Refractory Acute Myeloid Leukemia.
Want to learn more about this trial?
Request More InfoInterventions
CT0991 CAR-T cells infusicnDRUG
CAR-T cells# chimeric antigen receptor T cells#
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan | Hubei | China |